EXPLORE™ Spinal Muscular Atrophy Diagnosis and Treatment
The goal of this activity is to address knowledge and competence gaps related to SMA and the team approach required for patient identification, diagnosis, and treatment. An EXPLORE™ eLearning Module is an online educational program that has been uniquely designed by The France Foundation to allow for self-directed learning in a non-linear fashion, consisting of highly interactive elements, multimedia formats, and practical application tools, all developed in a micro-learning strategy.
Cost: FreeView Offer chevron_right
The France Foundation’s new EXPLORE™ modules put learners in the driver seat, allowing them to navigate content on their own time and driven by their own interests. This approach reduces virtual fatigue, ensures increased engagement and activity completions.
spinal muscular atrophy (SMA), diagnosing SMA in diverse clinical settings, key indicators of SMA, the importance of newborn screening, the impact of gene therapy as an early treatment for patients with SMA
- Recognize the signs and symptoms of spinal muscular atrophy as they present in diverse clinical settings
- Describe the consequences of delayed diagnosis for spinal muscular atrophy
- Assess the impact of early treatment of SMA and the team-based approach to patient management
This enduring activity is intended for physicians. It is also appropriate for the diverse spectrum of professionals who are involved in the identification, diagnosis, and treatment of SMA patients across multiple countries. These include medical geneticists, neurologists, pediatricians, genetic counselors, orthopedic surgeons, physical therapists, and speech pathologists, among others.
Additional credit info
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.